Clinical Trials Sponsored by Maastricht Radiation Oncology

Total 387 results

Maastricht Radiation Oncology

Recruiting

The Effect of 360° Virtual Reality Movies on Fear and Anxiety (ENGAGE)

Breast Cancer | Head and Neck Cancer | Anxiety | Lung Cancer | Prostate Cancer | Brain Tumor | Fear

Netherlands
Maastricht Radiation Oncology

Recruiting

Lung Cancer Organoids and Patient Derived Tumor Xenografts (Lung organoids)

Lung Cancer

Netherlands
Maastricht Radiation Oncology

Recruiting

Immune Profiling of Stage III Non-small Cell Lung Cancer Patients Treated With Concurrent Chemoradiation and Adjuvant Durvalumab: A Prospective Observational Phase II Trial (IPON-1)

Carcinoma, Non-Small-Cell Lung

Netherlands
Maastricht Radiation Oncology

Withdrawn

Standard of Care Lifestyle Support for Stage III NSCLC Patients (PERCUSSION)

Non Small Cell Lung Cancer
Maastricht Radiation Oncology

Completed

Immune Profiling After HDR in Local Relapsed Prostate Cancer (PRIMUS)

Prostate Cancer | PD-L1

Netherlands
Maastricht Radiation Oncology

Completed

The Addition of Chloroquine to Chemoradiation for Glioblastoma (CHLOROBRAIN)

Glioblastoma Multiforme

Netherlands
Maastricht Radiation Oncology

Completed

BioXmark, Rectal Feasibility Trial

Rectal Cancer

Netherlands
Maastricht Radiation Oncology

Completed

Predicting Outcome in Cervix Carcinoma: a Prospective Study (POCER)

Cervical Cancer

Netherlands, South Africa
Maastricht Radiation Oncology

Terminated

Tumor Hypoxia With HX4 PET in Several Diseases (HX4 SD)

Prostatic Neoplasms | Esophageal Neoplasms | Rectal Neoplasms | Brain Neoplasm, Primary | Neoplasm Metastases, Brain

Netherlands
Maastricht Radiation Oncology

Terminated

PET CT With HX4 in Cervix Cancer (HX4-cervix)

Cervix Cancer

Netherlands
Maastricht Radiation Oncology

Completed

Radiomics for Prediction of Survival in GBM (Radiomics)

Glioma | Glioblastoma | Astrocytoma

Netherlands
Maastricht Radiation Oncology

Withdrawn

Evaluation of Splenic Irradiation in Chronic Lymphatic Leukemia

Leukemia, Chronic Lymphatic

Netherlands
Maastricht Radiation Oncology

Completed

Concurrent Chemo-radiotherapy With Intensity-Modulated Radiation Therapy (IMRT) for Limited Disease Small Cell Lung Cancer (LD-SCLC)

Stage I-III Small Cell Lung Cancer

Netherlands
Maastricht Radiation Oncology

Withdrawn

DE-CT in Lung Cancer Proton Therapy (DE-CT)

Non Small Cell Lung Cancer

Netherlands
Maastricht Radiation Oncology

Completed

Rectal Study: Value of Repeated FDG-PET-CT Scans in Rectal Cancer

Rectum Cancer

Netherlands
Maastricht Radiation Oncology

Completed

Analysis of Treatment Outcome and Toxicity in Non-small Cell Lung Cancer Patients Wither-irradiated to a High Dose for Recurrent Disease

Non-small Cell Lung Cancer

Netherlands
Maastricht Radiation Oncology

Withdrawn

Re-irradiation of High Grade Gliomas: a Quality of Life Study

Glioblastoma Multiforme | Anaplastic Oligoastrocytoma | Anaplastic Astrocytoma

Netherlands
Maastricht Radiation Oncology

Completed

Safety Study of Individualised Radiation Dose Determination for Lung Cancer Patients.

Non-Small-Cell Lung Carcinoma

Netherlands
Maastricht Radiation Oncology

Completed

Concurrent Chemo-Radiotherapy for Limited Disease Small Cell Lung Cancer (LD-SCLC) on Basis of FDG-PET-Scans (BRONC 45 15)

Small Cell Lung Cancer

Netherlands
Maastricht Radiation Oncology

Recruiting

In Vivo Treatment Verification of Brachytherapy

Brachytherapy

Netherlands
Maastricht Radiation Oncology

Not yet recruiting

Re-induction of a Systemic Immune Response in Metastatic or Locally Recurrent Lung Cancer (Re-Induce 2)

Lung Cancer Stage IV

Netherlands
Maastricht Radiation Oncology

Active, not recruiting

Personal Health Train for Radiation Oncology in India and The Netherlands (TRAIN)

Head and Neck Carcinoma

India, Netherlands
Maastricht Radiation Oncology

Active, not recruiting

The Head and Neck Tumor Biobank

Head and Neck Squamous Cell Carcinoma

Netherlands
Maastricht Radiation Oncology

Completed

Prospective Primary Human Lungcancer Organoids to Predict Treatment Response (Organoids lung)

Lung Cancer

Netherlands
Maastricht Radiation Oncology

Completed

Exploratory Study on Therapy for Breath Hold in Radiotherapy

Breast Cancer | Lung Cancer

Netherlands
Maastricht Radiation Oncology

Completed

SDC for Lung Cancer Patients Treated With Curative Primary or Postoperative Radiotherapy or Chemoradiation (SDC lung)

Lung Cancer

Netherlands
Maastricht Radiation Oncology

Completed

Prospective Validation of 3D Dose Metrics as Selection Criteria for Adaptive Radiotherapy in Breast Cancer Patients

Breast Cancer

Netherlands
Maastricht Radiation Oncology

Completed

Adaptive Radiotherapy in Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

Netherlands
Maastricht Radiation Oncology

Completed

Radiomics for Prediction of Long Term Survival and Local Failure After Stereotactic Radiotherapy for Brain Metastases

Metastases, Neoplasm

Netherlands
Maastricht Radiation Oncology

Completed

PET With [18F]HX4 in Head and Neck Cancer

Cancer of the Head and Neck

Netherlands
Maastricht Radiation Oncology

Terminated

Defining the Radiotherapy Dose and Volume Parameters Affecting Postoperative Complications in Esophageal Cancer Patients

Esophageal Cancer

Netherlands
Maastricht Radiation Oncology

Completed

PET-CT Based Radiotherapy in Esophageal Cancer Patients

Esophageal Neoplasms

Netherlands
Maastricht Radiation Oncology

Completed

HI-CHART:Feasibility of High-Dose Accelerated Conformal Radiotherapy

Non-Small-Cell Lung Carcinoma

Netherlands
Maastricht Radiation Oncology

Recruiting

Outcome Prediction in Head&Neck Cancer Patients After Radiotherapy (OutcomeH&N)

Head and Neck Cancer

Netherlands
Maastricht Radiation Oncology

Withdrawn

The Addition of Chloroquine to Chemoradiation for Glioblastoma,

Glioblastoma | Astrocytoma, Grade IV
Maastricht Radiation Oncology

Active, not recruiting

Patient-derived Glioma Stem Cell Organoids

Glioblastoma

Netherlands
Maastricht Radiation Oncology

Terminated

Whole Brain Radiotherapy (WBRT) Versus Stereotactic Radiosurgery (SRS) for 4 Upto 10 Brain Metastases (WBRTvsSRS)

Neoplasm Metastasis

Netherlands
Maastricht Radiation Oncology

Terminated

Chloroquine as an Anti-autophagic Radiosensitizing Drug in Stage I-III Small Cell Lung Cancer (Chloroquine)

Small Cell Lung Cancer

Netherlands
Maastricht Radiation Oncology

Completed

Phase I Clinical Study Combining L19-IL2 With SABR in Patients With Oligometastatic Solid Tumor (L19-IL2)

Solid Tumour

Netherlands
Maastricht Radiation Oncology

Completed

Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone With Intensity-modulated Radiotherapy (IMRT) for Non Small Cell Lung Cancer (NSCLC) to an Individualised Mean Lung Dose (MLD)

Stage I-III Non-small Cell Lung Cancer

Netherlands
Maastricht Radiation Oncology

Withdrawn

Trial to Determine Optimal Phase II Dose of the Oral Dual CAIX Inhibitor/ Radiosensitizer

Head and Neck Neoplasms | Solid Tumors

Netherlands
Maastricht Radiation Oncology

Completed

Outpatient Clinic for Late Outcome for Breast Carcinoma in MAASTRO Clinic.

Breast Cancer

Netherlands
Maastricht Radiation Oncology

Completed

Validation of a Predictive Model After Complete Response in Rectal Cancer (Thunder)

Rectal Cancer

Netherlands
Maastricht Radiation Oncology

Completed

Nelfinavir, a Phase I/Phase II Rectal Cancer Study (Nelfinavir)

Colorectal Cancer | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, Colorectal

Netherlands
Maastricht Radiation Oncology

Completed

Usefulness of Blood Biomarkers for Overall Survival in NSCLC

Non-small Cell Lung Cancer

Netherlands
Maastricht Radiation Oncology

Completed

Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone for Patients With Oligo-metastatic Stage IV Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer | Stage IV (Oligo-metastases)

Netherlands
Maastricht Radiation Oncology

Completed

Radiotherapy for NSCLC to a Individualized MLD (BRONC MLD)

Non-small Cell Lung Cancer

Netherlands
Maastricht Radiation Oncology

Completed

Concurrent Chemo-radiation Form NSCLC to a Individualized MLD (BRONC CONC MLD)

Non-small Cell Lung Cancer

Netherlands
Maastricht Radiation Oncology
Maastricht University

Completed

Prone Breast Irradiation for Pendulous Breasts

Breast Cancer

Netherlands
Maastricht Radiation Oncology
Pfizer

Completed

Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC

Non Small Cell Lung Carcinoma

Netherlands

Clinical Trials Sponsored by Maastricht Radiation Oncology

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Egypt

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations